Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP286736.RAoZQcpcpzkWGCdiiyHeAi28f9tOeyTjkyB0i60Ki80Os130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP286736.RAoZQcpcpzkWGCdiiyHeAi28f9tOeyTjkyB0i60Ki80Os130_assertion type Assertion NP286736.RAoZQcpcpzkWGCdiiyHeAi28f9tOeyTjkyB0i60Ki80Os130_head.
- NP286736.RAoZQcpcpzkWGCdiiyHeAi28f9tOeyTjkyB0i60Ki80Os130_assertion description "[We used the allelic discrimination method to identify polymorphisms in GSTT1, SULT1C2, CDA, SXR (drug metabolic pathways), XPD, XPA, XPG, ERCC1, TOP2A (DNA repair), VEGF (angiogenesis), and MDR1 (multidrug resistance) genes in 110 adult patients with intermediate-risk AML, enrolled in the CETLAM-99 prospective trial.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP286736.RAoZQcpcpzkWGCdiiyHeAi28f9tOeyTjkyB0i60Ki80Os130_provenance.
- NP286736.RAoZQcpcpzkWGCdiiyHeAi28f9tOeyTjkyB0i60Ki80Os130_assertion evidence source_evidence_literature NP286736.RAoZQcpcpzkWGCdiiyHeAi28f9tOeyTjkyB0i60Ki80Os130_provenance.
- NP286736.RAoZQcpcpzkWGCdiiyHeAi28f9tOeyTjkyB0i60Ki80Os130_assertion SIO_000772 16507781 NP286736.RAoZQcpcpzkWGCdiiyHeAi28f9tOeyTjkyB0i60Ki80Os130_provenance.
- NP286736.RAoZQcpcpzkWGCdiiyHeAi28f9tOeyTjkyB0i60Ki80Os130_assertion wasDerivedFrom befree-20140225 NP286736.RAoZQcpcpzkWGCdiiyHeAi28f9tOeyTjkyB0i60Ki80Os130_provenance.
- NP286736.RAoZQcpcpzkWGCdiiyHeAi28f9tOeyTjkyB0i60Ki80Os130_assertion wasGeneratedBy ECO_0000203 NP286736.RAoZQcpcpzkWGCdiiyHeAi28f9tOeyTjkyB0i60Ki80Os130_provenance.